PureTech’s Seaport Therapeutics announces an oversubscribed $225 million Series B financing round
LONDON: PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) noted that its founded entity, Seaport Therapeutics, a biopharmaceutical company that is advancing novel neuropsychiatric medicines with...
Apogee Therapeutics as completes $149 million Series B financing round
LONDON, UK: Apogee Therapeutics LLC has completed $149 million Series B financing round. RTW Venture Fund, alongside other investment vehicles of RTW Investments LP participated...